UNSPSC 51282325: Erythromycin propionate

This classification denotes a macrolide antibiotic with the molecular formula C40H71NO14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HB75CIT999, chemically known as erythromycin, 2-propionate but more generally known as erythromycin propionate, which bears US NIH Compound Identifier 3258. European Medicines Agency schedules Erythromycin propionate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01945MIG.

UNSPSC 51282325 Erythromycin propionate is a Commodity code that nominally specifies a single pharmaceutical product, but recent state and local solicitations tagged to this code show minimal direct relevance to erythromycin itself. Instead, the code appears in opportunities for broader pharmaceutical procurement including naloxone, generic multi-source drugs, over-the-counter products, and medical supplies. State and local governments using this code are sourcing emergency response pharmaceuticals, community health supplies, and pharmacy benefit program products through a mix of issuing bodies: county health departments (Seminole County, Florida), state health commissions (Texas Health and Human Services Commission), city fire departments (Tampa Fire Department), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The work being solicited spans naloxone kits and drug deactivation systems for community health initiatives, direct-to-manufacturer prescription programs for state employee health plans, medical and first aid supplies for emergency response, and generic pharmaceuticals and OTC products for multi-state distribution through authorized wholesalers.

Recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023, with quarterly deliveries to Sanford, Florida); the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs (RFI posted April 3, 2026); the City of Tampa's ITB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000, with small local business enterprise set-aside and a 5% bid discount (due March 13, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon (due March 26, 2026). Geographic activity spans Florida, Texas, Minnesota, and Oregon, though the code shows limited concentration—the mismatch between the code's nominal pharmaceutical specification and the actual work being bought suggests this may not be the primary taxonomy for pharmaceutical procurement in most jurisdictions.